An automated microfluidic platform to screen ligands
Effective diagnostic technologies are essential for mitigating the devastating impact of infectious diseases. Identifying ligands that can target infectious disease biomarkers in patient samples is key to the function of modern diagnostics. However, current methods for ligand selection are slow and labour-intensive. Novel methods for automating ligand selection should increase the efficiency and capacity of communities to respond to disease outbreaks. The EU-funded microPhage project plans to develop a novel microfluidic device that could automate high-throughput ligand screening and apply it to generate novel ligands against an emerging HIV biomarker. The project will also explore novel microfluidic materials compatible with common ligand selection workflows.
Fields of science
Call for proposal
See other projects for this call